Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Raymond

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Scientific Reports|January 21, 2022
Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRIAkifumi Hagiwara, Hiroyuki Tatekawa, Jingwen Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
Journal of Neuro-Oncology|July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiationAkifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
European Radiology|October 26, 2023
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRIFrancesco Sanvito, Catalina Raymond, Nicholas S Cho, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroimage. Clinical|March 4, 2019
pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI)Benjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Scientific Reports|January 21, 2022
Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRIAkifumi Hagiwara, Hiroyuki Tatekawa, Jingwen Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
Journal of Neuro-Oncology|July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiationAkifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
European Radiology|October 26, 2023
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRIFrancesco Sanvito, Catalina Raymond, Nicholas S Cho, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroimage. Clinical|March 4, 2019
pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI)Benjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Pageof 7